Molina Healthcare (NYSE:MOH) Given Neutral Rating At Credit Suisse, Is a Move on The Horizon?

Share

How Credit Suisse Currently Rates Molina Healthcare (NYSE:MOH)

New York: Molina Healthcare (NYSE:MOH) coverage was initiated with a Neutral rating by investment analysts at Credit Suisse. This was revealed to clients in an analyst research report on Wednesday, 16 December.

From a total of 13 analysts covering Molina Healthcare (NYSE:MOH) stock, 7 rate it a ”Buy”, 0 a “Sell”, and 7 a ”Hold”. This means that 50% of the ratings are positive. The highest target price is $105 while the lowest target price is $65. The mean of all analyst targets is $84.62 with a 48.45% above today’s ($58.74) stock price. Molina Healthcare was the topic of 8 analyst reports since July 31, 2015 according to the firm StockzIntelligence Inc. Barclays Capital maintained shares on November 2 with “Equal Weight” rating. JP Morgan initiated MOH stock in a recent report from September 16 with “Neutral” rating. Finally, Stifel Nicolaus upgraded the stock to “Buy” rating in a report issued on a July 31.

Approximately 157,845 shares of stock traded hands. Molina Healthcare, Inc. (NYSE:MOH) has declined 14.21% since May 13, 2015 and is downtrending. It has underperformed by 11.59% the S&P500.

The overall sentiment of institutions has decreased to 1.58 in Q2 2015. Its down 0.80, from 2.38 in 2015Q2. The ratio is negative, as 31 institutions have sold all the shares of Molina Healthcare, Inc. that they owned while 80 funds have taken shares off the table. 55 funds have purchased shares for the first time while 120 added to their positions. These institutions now hold 45.35 million shares or 1.54% less than the 46.06 million shares they owned in 2015Q2.

The Fund Credit Capital Investments Llc currently is holding shares equating to 4.95% of its total portfolio in Molina Healthcare, Inc. representing a total of 107,147 shares. Another fund,Metropolitan Capital Advisors Inc, is holding a total of 60,200 shares equating to 3.81% of their holdings. Additionally, Orbimed Advisors Llc has a 3.24 million share stake in Molina Healthcare, Inc. which represents 2.25% of their total portfolio. The Fund, Ct Mason, based out of Massachusetts, has also built up a stake in the stock, which represents a total of 2.06% of their total portfolio. Finally Falcon Point Capital Llc, a fund which is based in the state of California reported a total holdings of 81,126 shares.

Insider activity is a very important aspect to track on any stock. Going back to March 5, 2015, shareholders of Molina Healthcare, Inc. have witnessed 0 insider buys, and a total of 19 sales equating to a net activity of approximately $11.65 million . Romney Ronna sold 250 shares worth approximately $16,443. Molina J Mario Md sold 20,000 shares worth approximately $1.37M. Molina John C sold 15,933 shares worth approximately $1.25 million. Orlando Steven J sold 2,500 shares worth approximately $196,500. The company insider Bayer Terry sold 11,433 shares worth $932,878.

Molina Healthcare, Inc. provides health care to those receiving Government assistance. The company has a market cap of $3.24 billion. The Firm offers Medicaid-related solutions for low-income families and individuals, and assists state agencies in their administration of the Medicaid program. It has 20.98 P/E ratio. The Firm operates through two divisions: Health Plans segment and Molina Medicaid Solutions segment.

According to Zacks Investment Research, “Molina Healthcare is a multi-state managed care organization that arranges for the delivery of healthcare services to persons eligible for Medicaid and other programs for low-income families and individuals. It currently operates health plans in California, Washington, Michigan and Utah.”

COMMENTS: